United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$140Mraised across 5 rounds since 2006, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $51M sold, first sale Jan 2010
Reported by fis.dowjones.comSEC filing: $13M sold, first sale Jan 2010
From a historical funding record
No investor was named in the report.
From a historical funding record
From the SEC filings it signed: 2 on the team.
On the board, as filediAtul M. SaranKent M. SnyderNicole M. VitulloPatrick M. HeronRon M. LauferSteven M. Gillis
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ARCH Venture Partners
Domain Associates
Frazier Healthcare PartnersMedImmune VenturesCelgeneMissing a round, or an investor who was in one? Tell us.
VentiRx Pharmaceuticals's investors include ARCH Venture Partners, Domain Associates, Frazier Healthcare Partners, MedImmune Ventures and Celgene.
VentiRx Pharmaceuticals has raised $140M across 5 rounds since 2006.
VentiRx Pharmaceuticals's most recent round was a Series B of $51M in Sept 2014.
Its most recent round, $51M in Sept 2014, is also its largest on record.
VentiRx Pharmaceuticals's first round on record, in Mar 2007, was backed by ARCH Venture Partners, Domain Associates and Frazier Healthcare Partners.
VentiRx Pharmaceuticals's latest named round is a Series B, in Sept 2014.
VentiRx Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
